Niogermox (Ciclopirox)

Ciclopirox, the active ingredient in Niogermox, is an antifungal presented as a topical formulation for skin application. It is used to treat fungal infections of the skin, nails and scalp in adult and pediatric patients where appropriate and can be applied once or twice daily as directed by a healthcare professional.

GNH USA supplies Niogermox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance and timely delivery.

Niogermox is a topical antifungal that targets dermatophyte and yeast infections of the skin and nails. - Tinea pedis: reduces fungal growth on the feet, relieving itching, scaling and redness. - Tinea corporis: clears body ringworm lesions by inhibiting the causative fungi. - Seborrheic dermatitis: controls Malassezia‑related scalp and facial flaking. - Onychomycosis: improves nail appearance by limiting fungal invasion of the nail plate. - Tinea versicolor: diminishes discoloration and scaling caused by Malassezia species.

Topical application of ciclopirox may be associated with local skin reactions, most of which are mild and reversible.

Common Side Effects: - Application site irritation: mild burning or stinging sensation. - Redness: localized erythema at the site of use. - Itching: transient pruritus. - Dryness: skin may become dry or flaky. - Scaling: mild flaking of the treated area. - Sensation of warmth: temporary feeling of heat.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, and blistering. - Angioedema: rapid swelling of face, lips or tongue. - Extensive skin necrosis: rare tissue damage at the application site. - Systemic hypersensitivity: anaphylactic reactions requiring emergency care. - Persistent ulceration: non‑healing sores where the product was applied.

When using Niogermox, certain precautions help minimize adverse reactions and ensure optimal effectiveness. - Avoid use on broken or inflamed skin: apply only to intact epidermis. - Do not cover treated area with occlusive dressings: may increase absorption and irritation. - Test on a small area first: perform a patch test to detect hypersensitivity. - Discontinue use if severe irritation occurs: seek medical advice promptly. - Keep away from eyes and mucous membranes: avoid accidental contact. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ciclopirox has a low potential for systemic drug interactions, but topical co‑applications can affect its safety profile.

Major Interactions (Avoid): - Concurrent use with other topical antifungal agents: may cause additive irritation. - Application together with strong corticosteroid creams: can mask infection signs and reduce efficacy.

Moderate Interactions (Monitor Closely): - Use with occlusive bandages: may increase drug absorption and local irritation. - Combination with systemic antifungal therapy: monitor for overlapping antifungal effects. - Co‑application with alcohol‑based cleansers: may alter drug film and reduce potency. - Use with phototoxic agents: monitor for increased skin sensitivity to light.